Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion type Assertion NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_head.
- NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion description "[Furthermore, loss of DAXX or ATRX correlated with tumor stage and metastasis, reduced time of relapse-free survival, and decreased time of tumor-associated survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_provenance.
- NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion evidence source_evidence_literature NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_provenance.
- NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion SIO_000772 24148618 NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_provenance.
- NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion wasDerivedFrom befree-2016 NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_provenance.
- NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_assertion wasGeneratedBy ECO_0000203 NP1121601.RA0IiT2tsGGKEhoo268f4cZv0giqmn6e5FNoyWurbAZFA130_provenance.